Further evaluating the benefit of adjuvant chemotherapy for colon cancer

Daniel J. Sargent; Thierry André; Axel Grothey

doi:10.1200/JCO.2016.68.4886

Further evaluating the benefit of adjuvant chemotherapy for colon cancer

Daniel J. Sargent, Thierry André, Axel Grothey

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	3711-3712
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	34
Issue number	30
DOIs	https://doi.org/10.1200/JCO.2016.68.4886
State	Published - Oct 20 2016

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2016.68.4886

Cite this

@article{5c64e8d771d74220b6e8558f933b03dc,

title = "Further evaluating the benefit of adjuvant chemotherapy for colon cancer",

author = "Sargent, {Daniel J.} and Thierry Andr{\'e} and Axel Grothey",

note = "Funding Information: Celgene (Inst), Genentech (Inst) Genentech (Inst), Bayer HealthCare Pharmaceuticals (Inst), Pfizer (Inst), Eisai (Inst), Sanofi (Inst), Eli Lilly (Inst), Boston Biomedical (Inst)",

year = "2016",

month = oct,

day = "20",

doi = "10.1200/JCO.2016.68.4886",

language = "English (US)",

volume = "34",

pages = "3711--3712",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "30",

}

TY - JOUR

T1 - Further evaluating the benefit of adjuvant chemotherapy for colon cancer

AU - Sargent, Daniel J.

AU - André, Thierry

AU - Grothey, Axel

N1 - Funding Information: Celgene (Inst), Genentech (Inst) Genentech (Inst), Bayer HealthCare Pharmaceuticals (Inst), Pfizer (Inst), Eisai (Inst), Sanofi (Inst), Eli Lilly (Inst), Boston Biomedical (Inst)

PY - 2016/10/20

Y1 - 2016/10/20

UR - http://www.scopus.com/inward/record.url?scp=84992091988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992091988&partnerID=8YFLogxK

U2 - 10.1200/JCO.2016.68.4886

DO - 10.1200/JCO.2016.68.4886

M3 - Letter

AN - SCOPUS:84992091988

SN - 0732-183X

VL - 34

SP - 3711

EP - 3712

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 30

ER -

Further evaluating the benefit of adjuvant chemotherapy for colon cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this